Sera Prognostics, Inc. – NASDAQ:SERA
Sera Prognostics stock price today
$2.25
-5.75
-71.87%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 1 hour
Sera Prognostics stock price monthly change
+26.18%
month
Sera Prognostics stock price quarterly change
+26.18%
quarter
Sera Prognostics stock price yearly change
+26.38%
year
Sera Prognostics key metrics
Market Cap | 288.02M |
Enterprise value | 87.23M |
P/E | -2.75 |
EV/Sales | 227.17 |
EV/EBITDA | -1.30 |
Price/Sales | 298.95 |
Price/Book | 1.16 |
PEG ratio | -0.09 |
EPS | -1.07 |
Revenue | N/A |
EBITDA | -35.48M |
Income | -33.77M |
Revenue Q/Q | -100% |
Revenue Y/Y | -37.57% |
Profit margin | -17685.94% |
Oper. margin | -18150.52% |
Gross margin | 29.95% |
EBIT margin | -18150.52% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSera Prognostics stock price history
Sera Prognostics stock forecast
Sera Prognostics financial statements
| Jun 2023 | 123K | -10.54M | -8570.73% |
|---|---|---|---|
| Sep 2023 | 42K | -7.21M | -17166.67% |
| Dec 2023 | 41K | -7.92M | -19329.27% |
| Mar 2024 | 0 | -8.09M |
| Sep 2025 | 3.50M | -6.53M | -186.16% |
|---|---|---|---|
| Oct 2025 | 3.45M | -6.43M | -186.08% |
| Dec 2025 | 4.94M | -5.73M | -115.87% |
| Dec 2025 | 5.10M | -5.57M | -109.14% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-08 | -0.3 | -0.23 |
|---|---|---|
| 2024-03-20 | -0.25 | -0.25 |
| 2024-05-08 | -0.23 | -0.25 |
| Jun 2023 | 96680000 | 15.54M | 16.08% |
|---|---|---|---|
| Sep 2023 | 90057000 | 14.64M | 16.26% |
| Dec 2023 | 95441000 | 25.28M | 26.49% |
| Mar 2024 | 89886000 | 25.13M | 27.96% |
| Jun 2023 | -7.94M | 12.90M | 124K |
|---|---|---|---|
| Sep 2023 | -7.59M | -15.16M | 128K |
| Dec 2023 | -6.76M | 374K | 616K |
| Mar 2024 | 4.99M | -5.68M | 1.05M |
Sera Prognostics alternative data
| Aug 2023 | 87 |
|---|---|
| Sep 2023 | 87 |
| Oct 2023 | 87 |
| Nov 2023 | 87 |
| Dec 2023 | 87 |
| Jan 2024 | 87 |
| Feb 2024 | 87 |
| Mar 2024 | 55 |
| Apr 2024 | 55 |
| May 2024 | 55 |
| Jun 2024 | 55 |
| Jul 2024 | 55 |
Sera Prognostics other data
18.76%
-3.96%
of SERA is owned by hedge funds
5.80M
-1.23M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 59762 |
| Mar 2024 | 0 | 171105 |
| May 2024 | 0 | 47882 |
| Jun 2024 | 0 | 32282 |
| Aug 2024 | 0 | 38587 |
| Sep 2024 | 0 | 30237 |
| Oct 2024 | 0 | 96 |
| Nov 2024 | 0 | 37608 |
| Dec 2024 | 0 | 32047 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | LINDGARDT ZHENYA director, officer: Chief Execut.. | Class A Common Stock | 26,224 | $7.41 | $194,320 | ||
Sale | AERTS AUSTIN officer: Chief Financial Officer | Class A Common Stock | 5,730 | $7.41 | $42,459 | ||
Sale | MIRZA MANSOOR RAZA director | Class A Common Stock | 93 | $7.12 | $662 | ||
Sale | MIRZA MANSOOR RAZA director | Class A Common Stock | 95 | $7.32 | $695 | ||
Sale | LINDGARDT ZHENYA director, officer: Chief Execut.. | Class A Common Stock | 12,075 | $7.32 | $88,389 | ||
Sale | KEARNEY PAUL officer: Chief Data Officer | Class A Common Stock | 4,078 | $7.32 | $29,851 | ||
Sale | JACKSON BENJAMIN officer: General Counsel | Class A Common Stock | 4,727 | $7.32 | $34,602 | ||
Sale | HARRISON ROBERT GARDNER officer: Chief Information Offi.. | Class A Common Stock | 4,727 | $7.32 | $34,602 | ||
Sale | BONIFACE JOHN J. officer: Chief Sc.. | Class A Common Stock | 4,727 | $7.32 | $34,602 | ||
Sale | AERTS AUSTIN officer: Chief Financial Officer | Class A Common Stock | 7,179 | $7.32 | $52,550 |
| Quarter | Transcript |
|---|---|
| Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 12 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 11 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Gregory C. Critchfield M.D., M.S. (1953) Executive Chairman, Chief Executive Officer & Pres | $513,830 |
Ms. Nadia F. Altomare (1970) Chief Commercial Officer | $410,620 |
| Dr. John J. Boniface (1962) Chief Scientific Officer | $386,690 |
-
What's the price of Sera Prognostics stock today?
One share of Sera Prognostics stock can currently be purchased for approximately $2.25.
-
When is Sera Prognostics's next earnings date?
Unfortunately, Sera Prognostics's (SERA) next earnings date is currently unknown.
-
Does Sera Prognostics pay dividends?
No, Sera Prognostics does not pay dividends.
-
How much money does Sera Prognostics make?
Sera Prognostics has a market capitalization of 288.02M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.18% to 306K US dollars. Sera Prognostics made a loss 36.24M US dollars in net income (profit) last year or -$0.25 on an earnings per share basis.
-
What is Sera Prognostics's stock symbol?
Sera Prognostics, Inc. is traded on the NASDAQ under the ticker symbol "SERA".
-
What is Sera Prognostics's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Sera Prognostics?
Shares of Sera Prognostics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sera Prognostics's key executives?
Sera Prognostics's management team includes the following people:
- Dr. Gregory C. Critchfield M.D., M.S. Executive Chairman, Chief Executive Officer & Pres(age: 72, pay: $513,830)
- Ms. Nadia F. Altomare Chief Commercial Officer(age: 55, pay: $410,620)
- Dr. John J. Boniface Chief Scientific Officer(age: 63, pay: $386,690)
-
How many employees does Sera Prognostics have?
As Jul 2024, Sera Prognostics employs 55 workers.
-
When Sera Prognostics went public?
Sera Prognostics, Inc. is publicly traded company for more then 4 years since IPO on 15 Jul 2021.
-
What is Sera Prognostics's official website?
The official website for Sera Prognostics is seraprognostics.com.
-
Where are Sera Prognostics's headquarters?
Sera Prognostics is headquartered at 2749 East Parleys Way, Salt Lake City, UT.
-
How can i contact Sera Prognostics?
Sera Prognostics's mailing address is 2749 East Parleys Way, Salt Lake City, UT and company can be reached via phone at 801 990 0520.
Sera Prognostics company profile:
Sera Prognostics, Inc.
seraprognostics.comExchange:
NASDAQ
Full time employees:
55
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
2749 East Parleys Way
Salt Lake City, UT 84109
Salt Lake City, UT 84109
CIK: 0001534969
ISIN: US81749D1072
CUSIP: 81749D107
